Embryonic stem cell therapy (Regenerative Patch Technologies)

N/A

Report date: 2024/11/02 20:00:07

Base Information

Drug NameEmbryonic stem cell therapy (Regenerative Patch Technologies)

Drug Alias NameCPCB-RPE1

ClassificationCell and gene therapy > Cell therapy > Somatic cell > Retinal pigment epithelial cell therapyCell and gene therapy > Cell therapy > Source of cells > Embryonic stem cell-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsGeographic Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRegenerative Patch Technologies Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRegenerative Patch Technologies Llc

Active IndicationsN/A

Inactive IndicationsGeographic Atrophy

Other Information

ATC CodeN/A